HBI Deals+Insights / M&A/IPOs
Laprophan Group, a Morocco-based pharmaceutical group, has acquired Swiss pharmaceutical company Rivopharm. The acquisition, completed through Europhan, Laprophan’s Luxembourg-based European platform, marks its first deal in Europe.





